Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma. - Wikidata - awgldk - TriplyDB

Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma.

Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma.

http://www.wikidata.org/entity/Q37203783

about

The suppressing effects of BTG3 expression on aggressive behaviors and phenotypes of colorectal cancer: An in vitro and vivo study.The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.BTG1 expression correlates with the pathogenesis and progression of ovarian carcinomas miR-139-5p controls translation in myeloid leukemia through EIF4G2.The function of BTG3 in colorectal cancer cells and its possible signaling pathway.BTG3 Overexpression Suppresses the Proliferation and Invasion in Epithelial Ovarian Cancer Cell by Regulating AKT/GSK3β/β-Catenin Signaling.BTG3 upregulation induces cell apoptosis and suppresses invasion in esophageal adenocarcinoma.

P2860

Q33566932-1FAC65DF-7E79-4D7A-9F82-E700BD569D6E Q35023159-A1FA426D-4490-41A5-B544-CE2B42C35B2D Q36260657-9281796B-9A11-428F-B1C8-262EA2C232CB Q37291160-FCCEF1E2-5037-49CF-BDDA-DCB052DE8A23 Q38854034-78013F35-AA0A-4E5C-8157-5EDDC54DE415 Q47261925-A31E5EF1-65ED-40BC-BEF8-3D67EABF8EB8 Q47864518-79A2A2F7-E544-44E7-A277-3AD9044090D1 Q52965377-4313B0DF-B417-4BDC-AC4F-3872A4E39A5B

P2860

Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma.

http://www.wikidata.org/entity/Q37203783

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Decreased expression of BTG3 w ...... rognosis of ovarian carcinoma.

@en

Decreased expression of BTG3 w ...... rognosis of ovarian carcinoma.

@nl

type

label

Decreased expression of BTG3 w ...... rognosis of ovarian carcinoma.

@en

Decreased expression of BTG3 w ...... rognosis of ovarian carcinoma.

@nl

prefLabel

Decreased expression of BTG3 w ...... rognosis of ovarian carcinoma.

@en

Decreased expression of BTG3 w ...... rognosis of ovarian carcinoma.

@nl

P1433

Q37203783-CFB59EED-B921-4AB2-B286-39E8E3B41625

P1476

Q37203783-6261D80D-7E5E-48DF-939D-F380145E0063

P2093

Q37203783-0D4A2786-3B2A-4D06-99CF-E2C71B1D1820

Q37203783-47A58751-F12D-44CA-AB96-76B5FEC98CF4

Q37203783-617913D1-3B81-4281-A512-ACFD5741ABEE

Q37203783-7D528554-C560-4A05-A46E-A83FE6EC5237

Q37203783-A3424517-3C9B-4A5C-ADD7-DFDD258AD8C3

Q37203783-E7E398A8-6386-49D2-8BC5-28D8306E1B4C

Q37203783-FD4F6EC0-9B6B-4210-A33C-8DCD64D869E1

P2860

Q37203783-254C7641-A15C-4AD4-9F17-1BA2049725B5

Q37203783-2C909B0D-0080-4873-A19A-DBE05C994165

Q37203783-32F43D11-36E6-4C47-AE2D-77D822BCD3FA

Q37203783-36A69533-AF8C-44A2-83D6-24738507FD4F

Q37203783-5174712C-8972-4237-87BD-ABB6F4E840B2

Q37203783-58E0E862-6719-4965-A90B-7658C0ED8551

Q37203783-607EBDCE-164D-4E55-AEA6-6D246B2A8B08

Q37203783-79C33B2C-FD4B-49AA-A016-76A5BB3E8F77

Q37203783-824EF89E-CEFE-4406-9859-617E4E5B50E4

Q37203783-8727B0D0-9835-41BE-9B7A-40035C0A9E53

P2888

Q37203783-C41F361E-D55C-400D-BF7A-134D3262AA28

P304

Q37203783-B3B12670-93C3-451D-81B1-2C513B69129C

P31

Q37203783-D5B7C81D-6350-4A82-A188-EFBCF6BE68CE

P356

Q37203783-353C1833-522A-418E-9135-16AFAC968437

P433

Q37203783-9D9329BF-AC5E-4CB4-A1BB-5970DD1FBF74

P478

Q37203783-8A9D8F1C-DEE0-442D-A338-4232457913AD

P577

Q37203783-BE058EA4-6E3D-49CF-86B4-3E374CC413B4

P5875

Q37203783-8CD0E743-9407-4917-A39F-00DE9B1EF68D

P698

Q37203783-3E4B71B8-AB0D-4084-AB3B-8311C1554F7E

P932

Q37203783-E17FE8A4-894F-4363-899B-C7288AC4CA1C

P356

S13277-013-0811-2

P1433

P1476

Decreased expression of BTG3 w ...... rognosis of ovarian carcinoma.

@en

P2093

Boya Deng

http://www.w3.org/2001/XMLSchema#string

Huachuan Zheng

http://www.w3.org/2001/XMLSchema#string

Shuo Chen

http://www.w3.org/2001/XMLSchema#string

Wenfeng Gou

http://www.w3.org/2001/XMLSchema#string

Xiaoyun Mao

http://www.w3.org/2001/XMLSchema#string

Yang Zhao

http://www.w3.org/2001/XMLSchema#string

Yasuo Takano

http://www.w3.org/2001/XMLSchema#string

P2860

The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex

The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1

Association of ANA, a member of the antiproliferative Tob family proteins, with a Caf1 component of the CCR4 transcriptional regulatory complex

Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system

The mammalian anti-proliferative BTG/Tob protein family

Nuclear localization of Tob is important for regulation of its antiproliferative activity

Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle

Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus

Cancer statistics, 2007

APRO4 negatively regulates Src tyrosine kinase activity in PC12 cells.

P2888

s13277-013-0811-2

P304

2617-2624

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-013-0811-2

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236666060

http://www.w3.org/2001/XMLSchema#string

P698

23657964

http://www.w3.org/2001/XMLSchema#string

P932

3785705

http://www.w3.org/2001/XMLSchema#string